• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大剂量屈大麻酚治疗与药用大麻花对比]

[High-dose dronabinol treatment vs. medicinal cannabis flowers].

作者信息

Wendelmuth Christoph, Gastmeier Knud

机构信息

Praxis Gastmeier, Karl-Marx-Str. 42, 14482, Potsdam, Deutschland.

出版信息

Schmerz. 2019 Oct;33(5):392-398. doi: 10.1007/s00482-019-00402-7.

DOI:10.1007/s00482-019-00402-7
PMID:31444574
Abstract

This article reports a case of pronounced, chronic lumboischialgia, which was not satisfactorily controlled by conventional analgesic treatment. The level of pain under high-dose dronabinol treatment with oral and inhalative administration as well as the way to reimburse the cost of medicinal cannabis flowers, the treatment success and criteria of the economic prescription procedure are presented.

摘要

本文报告了一例严重的慢性腰腿痛病例,常规镇痛治疗未能有效控制该症状。文中介绍了口服和吸入大剂量屈大麻酚治疗时的疼痛程度、药用大麻花朵费用的报销方式、治疗效果以及经济处方程序的标准。

相似文献

1
[High-dose dronabinol treatment vs. medicinal cannabis flowers].[大剂量屈大麻酚治疗与药用大麻花对比]
Schmerz. 2019 Oct;33(5):392-398. doi: 10.1007/s00482-019-00402-7.
2
[Cannabis as a therapeutic agent: Focal topic].[大麻作为一种治疗剂:焦点话题]
Schmerz. 2016 Feb;30(1):1-2. doi: 10.1007/s00482-015-0086-1.
3
Medical marijuana for cancer.医用大麻治疗癌症。
CA Cancer J Clin. 2015 Mar;65(2):109-22. doi: 10.3322/caac.21260. Epub 2014 Dec 10.
4
Medical use of cannabis products: Lessons to be learned from Israel and Canada.大麻产品的医学用途:从以色列和加拿大汲取的经验教训。
Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.
5
The effectiveness of self-directed medical cannabis treatment for pain.自我导向的医用大麻治疗疼痛的效果。
Complement Ther Med. 2019 Oct;46:123-130. doi: 10.1016/j.ctim.2019.07.022. Epub 2019 Jul 31.
6
[Cannabis - medicinal use].[大麻——药用]
Dtsch Med Wochenschr. 2014 Jan;139(3):74-5. doi: 10.1055/s-0033-1353961.
7
[Cannabis for medical purposes and its prescription].[医用大麻及其处方]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):811-817. doi: 10.1007/s00103-019-02970-6.
8
[Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North].[用于治疗慢性疼痛的大麻衍生药物:北法定医疗保险基金医疗咨询委员会经验中的医学评估所产生的问题]
Schmerz. 2019 Oct;33(5):437-442. doi: 10.1007/s00482-019-00397-1.
9
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.在欧洲,用于慢性疼痛管理和姑息/支持性治疗的基于大麻的药物的可及性和批准情况:对欧洲疼痛联合会各章节现状的调查。
Eur J Pain. 2018 Mar;22(3):440-454. doi: 10.1002/ejp.1147. Epub 2017 Nov 13.
10
The use of medical-grade cannabis in patients non-responders to Nabiximols.医用大麻在对纳布西莫尔无反应患者中的应用。
J Neurol Sci. 2016 Sep 15;368:349-51. doi: 10.1016/j.jns.2016.07.059. Epub 2016 Jul 26.

引用本文的文献

1
[Three years of cannabis as medicine-preliminary results of the survey accompanying the prescription of medical cannabis in Germany].[三年医用大麻——德国医用大麻处方随附调查的初步结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Mar;64(3):368-377. doi: 10.1007/s00103-021-03285-1. Epub 2021 Feb 9.

本文引用的文献

1
Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.美国中年和老年人 2015-2016 年处方阿片类药物滥用情况。
Prev Med. 2019 Apr;121:94-98. doi: 10.1016/j.ypmed.2019.02.018. Epub 2019 Feb 11.
2
Cannabinoid Ligands Targeting TRP Channels.靶向瞬时受体电位通道的大麻素配体
Front Mol Neurosci. 2019 Jan 15;11:487. doi: 10.3389/fnmol.2018.00487. eCollection 2018.
3
European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management.
欧洲疼痛联合会(EFIC)关于慢性疼痛管理中合理使用大麻素药物和医用大麻的立场文件。
Eur J Pain. 2018 Oct;22(9):1547-1564. doi: 10.1002/ejp.1297. Epub 2018 Sep 4.
4
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.疼痛与炎症中的内源性大麻素系统:其与风湿性疾病的相关性。
Eur J Rheumatol. 2017 Sep;4(3):210-218. doi: 10.5152/eurjrheum.2017.17025. Epub 2017 Sep 1.
5
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.用于未来治疗的阿片受体变构调节剂领域的最新进展
ACS Chem Neurosci. 2017 Jun 21;8(6):1147-1158. doi: 10.1021/acschemneuro.7b00090. Epub 2017 Apr 7.
6
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.大麻素类药物的阿片类药物节约效应:系统评价和荟萃分析。
Neuropsychopharmacology. 2017 Aug;42(9):1752-1765. doi: 10.1038/npp.2017.51. Epub 2017 Mar 22.
7
Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.结肠炎中内源性大麻素系统的调控:综述
Inflamm Bowel Dis. 2017 Feb;23(2):192-199. doi: 10.1097/MIB.0000000000001004.
8
Drug development: The treasure chest.药物研发:宝库。
Nature. 2015 Sep 24;525(7570):S6-8. doi: 10.1038/525S6a.
9
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.靶向CB1和TRPV1、交感神经系统以及关节炎的大麻素类药物。
Arthritis Res Ther. 2015 Sep 6;17(1):226. doi: 10.1186/s13075-015-0743-x.
10
The investigation and differential diagnosis of Asperger syndrome in adults.成人 Asperger 综合征的调查与鉴别诊断。
Dtsch Arztebl Int. 2013 Nov 8;110(45):755-63. doi: 10.3238/arztebl.2013.0755.